China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Ustekinumab Combined with Upadacitinib Promotes Mucosal Healing in Patients with Active Crohn's Disease Who Failed Anti-TNF-α Therapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131793
Registration Time: 2026/09/07
Type: Observational study
Primary Sponsor: Shanghai Tenth People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=296203
Published by HT Digital Content Services with permission from Health Daily Digest....